Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease

Clin J Am Soc Nephrol. 2021 Dec 1:CJN.13601021. doi: 10.2215/CJN.13601021. Online ahead of print.NO ABSTRACTPMID:34853063 | DOI:10.2215/CJN.13601021

Source: Clinical Journal of the American Society of Nephrology : CJASN - December 2, 2021 Category: Urology & Nephrology Authors: Alberto Ortiz Beatriz Fernandez-Fernandez Source Type: research